HIPEC is a specialised treatment that combines surgery with heated chemotherapy to target microscopic cancer cells remaining in the abdominal cavity after tumour removal.

Building on its experience, Kauvery Hospital is launching a dedicated centre for HIPEC and Cytoreductive Surgery to advance abdominal cancer care.
Kauvery Hospital has completed over 200 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedures, making it one of the few hospitals in the state with this level of experience in treating cancers that have spread to the lining of the abdomen (peritoneum).
Building on this experience, Kauvery Hospital has also launched a dedicated centre for HIPEC and Cytoreductive Surgery to further strengthen its expertise in treating advanced abdominal cancers.
HIPEC delivers heated chemotherapy directly into the abdominal cavity during cytoreductive surgery, the operation that aims to remove all visible tumour deposits. Its main purpose is to kill microscopic cancer cells that remain after the surgery. Combining the two allows concentrated treatment at the disease site, with less of the drug reaching the rest of the body.
The treatment is performed in carefully selected patients with cancers that have spread within the abdominal cavity, including ovarian and colorectal cancers, as well as other cancers affecting the abdominal lining.
HIPEC is offered only at select centres in the country, as it is a team-based, resource-intensive treatment requiring a highly trained multidisciplinary team, specialised equipment and careful patient selection. The team comprises surgical oncologists, medical oncologists, anaesthetists, intensivists, pathologists, radiologists and nutritionists, supported by nursing staff experienced in caring for these patients.
Expertise in cytoreductive surgery is particularly crucial, as treatment outcomes depend significantly on how completely the surgeon removes visible cancer deposits from the abdominal cavity. Advanced imaging and, where necessary, laparoscopic staging help assess the extent of disease spread and identify patients who are most likely to benefit from the procedure.
The procedure also requires specialised perfusion machines that heat the chemotherapy solution to approximately 41-43┬░C, circulate it within the abdominal cavity and continuously monitor its temperature. Since the surgery is prolonged and can involve considerable blood loss and heat stress, an experienced anaesthesia and critical care team is equally essential.
Commenting on the milestone, Dr. Sujay Susikar, Senior Consultant Surgical Oncology, Kauvery Hospital, said, тАЬWe are happy to have crossed the milestone of 200 HIPEC procedures, which reflects our teamтАЩs experience and commitment to delivering advanced cancer care. HIPEC offers an important treatment option for patients with advanced cancers that have spread to the peritoneum, a condition that was once considered extremely difficult to treat. Conventional intravenous chemotherapy may not adequately reach cancer deposits in this region. HIPEC addresses this limitation by circulating heated chemotherapy directly within the abdominal cavity following surgery to remove visible tumours. This helps target microscopic cancer cells that may remain after surgery, improving treatment possibilities for carefully selected patients who previously had very limited options.тАЭ
In his comments, Dr Aravindan Selvaraj, Co Founder and Executive Director, Kauvery Group of Hospitals, said, тАЬAdvanced abdominal cancers have always been among the most challenging to treat. With HIPEC, we are able to extend meaningful treatment options for patients who earlier had very limited choices. At Kauvery Hospital, our focus has been on combining the right infrastructure, clinical expertise, and a multidisciplinary approach to deliver outcomes that truly make a difference in patientsтАЩ lives. This integrated approach has also enabled us to care for patients from across geographies, who place their trust in our team for complex cancer treatment.тАЭ

